1,374 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
NVS Novartis AG $85.13 $197.65B N/A
Article Searches
Franklin Resources Inc Buys Qiagen NV, Baker Hughes Inc, Williams Inc, Sells St Jude Medical ... http://www.gurufocus.com/news/532969/franklin-resources-inc-buys-qiagen-nv-baker-hughes-inc-williams-inc-sells-st-jude-medical-inc-the-mosaic-co-deere Jun 15, 2017 - Franklin Resources Inc Buys Qiagen NV, Baker Hughes Inc, Williams Inc, Sells St Jude Medical Inc, The Mosaic Co, Deere, Stocks: BHI,WMB,ORCL,MYL,XOM,VZ,QGEN,EXXI,SBAC,SGY,FTI,THC, release date:Jun 15, 2017
Novartis (NVS) Announced Positive Data on Psoriasis Cosentyx http://feeds.benzinga.com/~r/benzinga/~3/24s-1Weu0NE/novartis-nvs-announced-positive-data-on-psoriasis-cosentyx Jun 15, 2017 -

Novartis AG NVS announced positive data on arthritis drug Cosentyx from two phase III studies at the Annual European Congress of Rheumatology (EULAR 2017), in Madrid.

read more

Why Is ImmunoGen (IMGN) Stock Up 131% This Year? http://www.zacks.com/stock/news/264477/why-is-immunogen-imgn-stock-up-131-this-year?cid=CS-ZC-FT-264477 Jun 15, 2017 - Shares of ImmunoGen, Inc. (IMGN) are massively up 130.9% this year so far, outperforming the the Zacks classified Medical-Drugs industry's registered 3.6% increase during this period.
Get Paid While You Wait: 3 Top Dividend Stocks in Big Pharma https://www.fool.com/investing/2017/06/09/get-paid-while-you-wait-3-top-dividend-stocks-in-b.aspx?source=iedfolrf0000001 Jun 09, 2017 - Good things come to those income investors who wait.
3 Stocks to Buy With Dividends Yielding 3% or More https://www.fool.com/investing/2017/06/08/3-stocks-to-buy-with-dividends-yielding-3-or-more.aspx?source=iedfolrf0000001 Jun 08, 2017 - Looking for both good yields and solid business prospects is important. These stocks deliver the goods.
Novartis Presents Data on Tafinlar-Mekinist Combination http://www.zacks.com/stock/news/263072/novartis-presents-data-on-tafinlar-mekinist-combination?cid=CS-ZC-FT-263072 Jun 05, 2017 - Novartis AG (NVS) announced results from a phase II study, BRF113220, on the combination of Tafinlar and Mekinist at the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO).
Novartis AG (NVS) Investor Presentation - Slideshow https://seekingalpha.com/article/4078060-novartis-ag-nvs-investor-presentation-slideshow?source=feed_all_articles Jun 01, 2017 - The following slide deck was published by Novartis AG in conjunction with this event.
Novartis Biosimilar Pipeline, 2018 Growth Plans on Track http://www.zacks.com/stock/news/262554/novartis-biosimilar-pipeline-2018-growth-plans-on-track?cid=CS-ZC-FT-262554 May 31, 2017 - Novartis AG (NVS) announced that the EMA has accepted its applications for biosimilar versions of AbbVie's (ABBV) Humira (adalimumab) and Johnson & Johnson's (JNJ) Remicade (infliximab) for review.
Celgene's Stock May Be Incredibly Overvalued Right Now -- Here's Why https://www.fool.com/investing/2017/05/31/celgenes-stock-may-be-incredibly-overvalued-right.aspx?source=iedfolrf0000001 May 31, 2017 - Celgene's long thesis might be unraveling.
5 Drug Stocks in Focus on World MS Day http://www.zacks.com/stock/news/262510/5-drug-stocks-in-focus-on-world-ms-day?cid=CS-ZC-FT-262510 May 31, 2017 - Life with MS -- this world MS day, here's a look at 5 stocks including Biogen (BIIB) that are key players in the multiple sclerosis (MS) market.
<<<Page 117>